Yril Ossa: Pharmaceutical Biotech Medical Device
Yril Ossa: Pharmaceutical Biotech Medical Device
Yril Ossa: Pharmaceutical Biotech Medical Device
Accountable and accomplished Director of Quality with over 20+ years experience in Quality Management in various
companies ranging from clinical to commercial. Expertise in the areas of validation technology and evaluating trends in FDA
regulated industries. Spectrum of professional knowledge includes: Aseptic Filling, Solid Dosage, Medical Devices, Cell Culture,
Tissue Engineering and Immunotherapy. Ability to balance regulatory, science and business needs as well as coach and develop
quality professionals to meet and exceed the challenges of their daily work.
Extensive expertise in the development, testing, implementing and leading of various Quality functions as well as
streamlining the Quality process while complying with government regulations. Adept at interfacing with regulatory bodies such
as the FDA, ISO, TGA (Australian) and EMA (EU). Partner with contract manufacturing organizations, engineering department,
operations, QC, IT and executive leadership. Dedicated to apply sound engineering principles to provide solutions and options
that meet the business and regulatory requirements.
AREAS
OF
STRENGTH
QA Compliance
Change Control Management
GMP Best Practices
Project Management
Calibration & Maintenance
Compliance Remediation
PROFESSIONAL EXPERIENCE
Gilead Sciences, Foster City, CA
Principal Quality Consultant, 2014-Present
Challenged to manage equipment validation of a new solid dosage pilot plant used for clinical manufacturing.
Provide management support.
Resolved various deviations by working closely with Quality Assurance.
Genzyme (a Sanofi Company), Boston, MA
Director of QA, Global QA Consent Decree Management Office, 2012-2014
Led teams through work plan deadlines for the consent decree.
Successfully delivered against penalty related milestones agreed with FDA.
Strategically collaborated with third party verifiers to complete in-place and in-use validation programs.
Executed gap assessments against new corporate standards in order to achieve verification.
Successfully accomplished the remediation steps for in-use verification for the Validation Life Cycle, the Lab Equipment
Qualification, Storage and Distribution, and the Requalification programs numbered steps.
Dendreon Corporation, Seattle, WA
Senior Director, Corporate Validation, Quality Department, 2004-2011
Leveraged extensive knowledge of Quality and Validation Management to organize and establish a Corporate Validation
program consisting of Validation Engineering at all facilities, a corporate Computer Systems Validation group and a
corporate Process/CMO Validation group.
Successfully passed the PAI inspection of the first US commercial Immunotherapy Manufacturing Facility in 2010 located in
NJ.
Managed the Validation process for two additional sites in the US (CA & GA) as well as a CMO site in Europe.
Implemented Corporate Policies for all commercial sites in the US and clinical site in the EU.
www.linkedin.com/in/cyrilpossa
Page 1 of 3
www.linkedin.com/in/cyrilpossa
Page 2 of 3
PROFESSIONAL AFFILIATIONS
Member of the Institute of Validation Technology (IVT)
Member of The International Society for Pharmaceutical Engineering (ISPE)
Member of the Parenteral Drug Association (PDA)
www.linkedin.com/in/cyrilpossa
Page 3 of 3